Literature DB >> 28636926

Enhanced human bone marrow mesenchymal stromal cell adhesion on scaffolds promotes cell survival and bone formation.

Miryam Mebarki1, Laura Coquelin1, Pierre Layrolle2, Séverine Battaglia2, Marine Tossou1, Philippe Hernigou3, Hélène Rouard1, Nathalie Chevallier4.   

Abstract

In order to induce an efficient bone formation with human bone marrow mesenchymal stromal cells (hBMSC) associated to a scaffold, it is crucial to determine the key points of the hBMSC action after in vivo transplantation as well as the appropriate features of a scaffold. To this aim we compared the hBMSC behavior when grafted onto two biomaterials allowing different bone potential in vivo. The cancellous devitalized Tutoplast®-processed bone (TPB) and the synthetic hydroxyapatite/β-tricalcium-phosphate (HA/βTCP) which give at 6weeks 100% and 50% of bone formation respectively. We first showed that hBMSC adhesion is two times favored on TPB in vitro and in vivo compared to HA/βTCP. Biomaterial structure analysis indicated that the better cell adhesion on TPB is associated to its higher and smooth open pore architecture as well as its content in collagen. Our 6week time course analysis, showed using qPCR that only adherent cells are able to survive in vivo giving thus an advantage in term of cell number on TPB during the first 4weeks after graft. We then showed that grafted hBMSC survival is crucial as cells participate directly to bone formation and play a paracrine action via the secretion of hIGF1 and hRANKL which are known to regulate the bone formation and resorption pathways respectively. Altogether our results point out the importance of developing a smooth and open pore scaffold to optimize hBMSC adhesion and ensure cell survival in vivo as it is a prerequisite to potentiate their direct and paracrine functions. STATEMENT OF SIGNIFICANCE: Around 10% of skeletal fractures do not heal correctly causing nonunion. An approach involving mesenchymal stromal cells (MSC) associated with biomaterials emerges as an innovative strategy for bone repair. The diversity of scaffolds is a source of heterogeneity for bone formation efficiency. In order to better determine the characteristics of a powerful scaffold it is crucial to understand their relationship with cells after graft. Our results highlight that a biomaterial architecture similar to cancellous bone is important to promote MSC adhesion and ensure cell survival in vivo. Additionally, we demonstrated that the grafted MSC play a direct role coupled to a paracrine effect to enhance bone formation and that both of those roles are governed by the used scaffold.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterial; Bone tissue engineering; Cell therapy; HA/βTCP; Mesenchymal stem cells; Tutoplast

Mesh:

Substances:

Year:  2017        PMID: 28636926     DOI: 10.1016/j.actbio.2017.06.018

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  18 in total

1.  Recent Advances in Biomaterials for the Treatment of Bone Defects.

Authors:  Le-Yi Zhang; Qing Bi; Chen Zhao; Jin-Yang Chen; Mao-Hua Cai; Xiao-Yi Chen
Journal:  Organogenesis       Date:  2020-08-16       Impact factor: 2.500

2.  Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies.

Authors:  Zhen Wang; Xinghua Song; Abulikemu Maimaitiaili; Tengfei Wang
Journal:  Infect Drug Resist       Date:  2021-05-14       Impact factor: 4.003

3.  A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol.

Authors:  Enrique Gómez-Barrena; Norma G Padilla-Eguiluz; Cristina Avendaño-Solá; Concepción Payares-Herrera; Ana Velasco-Iglesias; Ferran Torres; Philippe Rosset; Florian Gebhard; Nicola Baldini; Juan C Rubio-Suarez; Eduardo García-Rey; José Cordero-Ampuero; Javier Vaquero-Martin; Francisco Chana; Fernando Marco; Javier García-Coiradas; Pedro Caba-Dessoux; Pablo de la Cuadra; Philippe Hernigou; Charles-Henri Flouzat-Lachaniette; François Gouin; Didier Mainard; Jean Michel Laffosse; Miriam Kalbitz; Ingo Marzi; Norbert Südkamp; Ulrich Stöckle; Gabriela Ciapetti; Davide Maria Donati; Luigi Zagra; Ugo Pazzaglia; Guido Zarattini; Rodolfo Capanna; Fabio Catani
Journal:  Stem Cells Int       Date:  2018-02-22       Impact factor: 5.443

4.  Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a study based on a three-dimensional biomimetic environment.

Authors:  Guan Zheng; Zhongyu Xie; Peng Wang; Jinteng Li; Ming Li; Shuizhong Cen; Su'an Tang; Wenjie Liu; Guiwen Ye; Yuxi Li; Shan Wang; Xiaohua Wu; Hongjun Su; Yanfeng Wu; Huiyong Shen
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

5.  Evaluation of bone allograft processing methods: Impact on decellularization efficacy, biocompatibility and mesenchymal stem cell functionality.

Authors:  Alexander Rasch; Hendrik Naujokat; Fanlu Wang; Andreas Seekamp; Sabine Fuchs; Tim Klüter
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

Review 6.  Innovative Biomaterials for Bone Regrowth.

Authors:  Maria Rosa Iaquinta; Elisa Mazzoni; Marco Manfrini; Antonio D'Agostino; Lorenzo Trevisiol; Riccardo Nocini; Leonardo Trombelli; Giovanni Barbanti-Brodano; Fernanda Martini; Mauro Tognon
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

7.  The effectiveness of hydroxyapatite-beta tricalcium phosphate incorporated into stem cells from human exfoliated deciduous teeth for reconstruction of rat calvarial bone defects.

Authors:  Alexandre Augusto Ferreira da Silva; Ugo Guilherme Roque Rinco; Ricardo Garcia Mureb Jacob; Vivien Thiemy Sakai; Ronaldo Célio Mariano
Journal:  Clin Oral Investig       Date:  2021-06-24       Impact factor: 3.573

Review 8.  Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.

Authors:  Silvia Baldari; Giuliana Di Rocco; Martina Piccoli; Michela Pozzobon; Maurizio Muraca; Gabriele Toietta
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

9.  Human salivary histatin-1 (Hst1) promotes bone morphogenetic protein 2 (BMP2)-induced osteogenesis and angiogenesis.

Authors:  Ping Sun; Andi Shi; Chenxi Shen; Yi Liu; Gang Wu; Jianying Feng
Journal:  FEBS Open Bio       Date:  2020-06-29       Impact factor: 2.693

10.  Mineralized collagen scaffold bone graft accelerate the osteogenic process of HASCs in proper concentration.

Authors:  Weiyang Zuo; Lingjia Yu; Haiyan Zhang; Qi Fei
Journal:  Regen Ther       Date:  2021-06-27       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.